Learn languages naturally with fresh, real content!

tap to translate recording

Explore By Region

flag New drug baxdrostat shows promise in reducing blood pressure and kidney risks in kidney disease patients.

flag A new drug, baxdrostat, shows promise in lowering high blood pressure in patients with chronic kidney disease. flag The Phase 2 trial found it reduced systolic blood pressure by 5% and decreased a kidney risk marker by 55%. flag While effective, it caused high potassium levels in some patients. flag The drug's success could improve long-term health outcomes for those with uncontrolled blood pressure and kidney disease.

3 Articles